Literatura científica selecionada sobre o tema "Medulloblastoma paediatric"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Índice
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Medulloblastoma paediatric".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "Medulloblastoma paediatric"
Tan, Geok Chin. "Molecular Subtyping of Paediatric Medulloblastoma by Immunohistochemistry". Medicine & Health 15, n.º 2 (31 de dezembro de 2020): 124–39. http://dx.doi.org/10.17576/mh.2020.1502.13.
Texto completo da fonteAbbas, Zahra, Jessica Buck, Mathew Ancliffe, Clara Andradas Arias, Meegan Howlett, Hilary Hii, Terrance Johns, Siddhartha Mitra, Nicholas Gottardo e Raelene Endersby. "MODL-18. Enhancing anti-CD47 mAb efficacy with radiotherapy for Group 3 paediatric medulloblastoma in preclinical models". Neuro-Oncology 24, Supplement_1 (1 de junho de 2022): i172—i173. http://dx.doi.org/10.1093/neuonc/noac079.641.
Texto completo da fonteLasseini, Ali, Aliyu Muhammad Koko e Ashafa Birnin Gwari Isa. "Demographic and Interventional Pattern of Pediatric Brain Tumors Managed at UDUTH Sokoto: A Decade Review". International Journal of Research and Review 10, n.º 10 (21 de outubro de 2023): 374–77. http://dx.doi.org/10.52403/ijrr.20231045.
Texto completo da fonteTang, Phua Hwee, Sharon Low, Enrica Tan e Kenneth Chang. "IMG-01. DWI RATIO OF HISTOLOGICAL MOLECULAR SUBTYPES OF PAEDIATRIC MEDULLOBLASTOMAS". Neuro-Oncology 22, Supplement_3 (1 de dezembro de 2020): iii354. http://dx.doi.org/10.1093/neuonc/noaa222.337.
Texto completo da fonteGrosshans, David R. "Proton therapy for paediatric medulloblastoma". Lancet Oncology 17, n.º 3 (março de 2016): 258–59. http://dx.doi.org/10.1016/s1470-2045(15)00217-x.
Texto completo da fonteBurki, Talha Khan. "Postoperative radiotherapy for paediatric medulloblastoma". Lancet Oncology 17, n.º 9 (setembro de 2016): e381. http://dx.doi.org/10.1016/s1470-2045(16)30390-4.
Texto completo da fontePadovani, L., G. Horan e T. Ajithkumar. "Radiotherapy Advances in Paediatric Medulloblastoma Treatment". Clinical Oncology 31, n.º 3 (março de 2019): 171–81. http://dx.doi.org/10.1016/j.clon.2019.01.001.
Texto completo da fonteMcLendon, Friedman, Fuchs, Kun e Bigner. "Diagnostic markers in paediatric medulloblastoma: a Paediatric Oncology Group Study". Histopathology 34, n.º 2 (fevereiro de 1999): 154–62. http://dx.doi.org/10.1046/j.1365-2559.1999.00577.x.
Texto completo da fonteWong, Gabriel Chun-Hei, Queenie Junqi Huang, Manix Fung Man Poon, Nellie Yuk-Fei Chung, Queenie Hoi-Wing Wong, Zhen-Yu Zhang, Zhi-Feng Shi et al. "PATH-32. CLINICAL AND MUTATIONAL PROFILES OF ADULT MEDULLOBLASTOMA GROUPS". Neuro-Oncology 22, Supplement_2 (novembro de 2020): ii171. http://dx.doi.org/10.1093/neuonc/noaa215.713.
Texto completo da fonteAllen, Joseph, Susannah Entwistle, Beth Coyle e Alistair N. Hume. "MDB-46. ARE RAB40 SMALL GTPASES DRIVERS OF MEDULLOBLASTOMA PATHOGENESIS?" Neuro-Oncology 26, Supplement_4 (18 de junho de 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.495.
Texto completo da fonteTeses / dissertações sobre o assunto "Medulloblastoma paediatric"
Nasir, Aishah. "An investigation of metastatic markers in models of paediatric medulloblastoma". Thesis, University of Nottingham, 2017. http://eprints.nottingham.ac.uk/42405/.
Texto completo da fonteMather, Rebecca Louise. "Deacetylation of GD3A as a potential therapeutic strategy for paediatric medulloblastoma". Thesis, University of Portsmouth, 2016. https://researchportal.port.ac.uk/portal/en/theses/deacetylation-of-gd3a-as-a-potential-therapeutic-strategy-for-paediatric-medulloblastoma(d5e04f18-7985-48ff-807a-0962e6037835).html.
Texto completo da fonteNair, Omesan. "Profiling medulloblastoma and juvenile pilocytic astrocytoma brain tumours in a South African paediatric cohort". Doctoral thesis, University of Cape Town, 2017. http://hdl.handle.net/11427/26896.
Texto completo da fonteGeorge, Courtney M. "Medulloblastoma: New animal models, preclinical drug testing, and characterising immune infiltrates". Thesis, Edith Cowan University, Research Online, Perth, Western Australia, 2022. https://ro.ecu.edu.au/theses/2575.
Texto completo da fonteOkiro, Patricia Opon. "Morphological classification of childhood medulloblastomas with β-catenin immunohistochemistry and mycn fluorescent in situ hybridization". Master's thesis, University of Cape Town, 2015. http://hdl.handle.net/11427/15733.
Texto completo da fontePenco-Campillo, Manon. "Le VEGFC et les récepteurs CXCR1/2 : des cibles pertinentes pour le traitement des médulloblastomes pédiatriques". Electronic Thesis or Diss., Université Côte d'Azur, 2022. http://www.theses.fr/2022COAZ6025.
Texto completo da fonteMedulloblastoma (MB) is the most common and aggressive pediatric brain tumor. Despite aggressive multimodal treatment, resulting in significant side effects, 30% of patients develop resistance and relapse following the appearance of metastases within 5 years. Recurrences cannot be controlled by conventional (radio- and chemotherapy) or targeted (anti-angiogenic, anti-inflammatory, anti-immune checkpoint) treatments. The objective of my thesis is therefore to discover new targets and relevant therapeutic strategies for these patients at diagnosis or after a relapse.MBs are highly vascularized tumors. The phenomenon of resistance is, in part, linked to the development of blood (angiogenesis) and lymphatic (lymphangiogenesis) vessels in the tumor, which constitute the main routes of metastatic dissemination. The lymphatic growth factor, VEGFC, and its receptors/co-receptors are the major players in lymphangiogenesis. In the first part of my thesis, I showed that VEGFC is inversely correlated to MB cell growth and aggressiveness. Indeed, VEGFC decreases the proliferation and migration of MB cells, as well as their ability to form pseudo-vessels in vitro, by an autocrine signalization. Cells resistant to radiotherapy show elevated levels of VEGFC and lose their ability to migrate and form pseudo-vessels. Irradiation reduces the aggressiveness of MB cells by a VEGFC-dependent process. VEGFC-overexpressing cells and radiation-resistant cells form smaller experimental tumors in nude mice. Thus, VEGC appears to be a negative regulator of MB growth. These results pave the way for the development of pro-VEGFC therapies in these cancers.In the second part of my thesis, I correlated the expression of the ELR+CXCL/CXCR1-2 pro-angiogenic and pro-inflammatory signaling pathway to shorter survival in patients with MB. I showed that a novel pharmacological inhibitor (C29) of CXCR1-2 receptors inhibits proliferation, CXCL8/CXCR1-2-dependent migration, invasion and pseudo-vessel formation by susceptible or resistant MB cells to radiotherapy. C29 reduces the growth of experimental MBs in an ex vivo organotypic mouse model and crosses the blood-brain barrier. Thus, targeting CXCR1-2 represents a promising strategy for the treatment of pediatric MB, at first line or at relapse.Key words: pediatric medulloblastoma, VEGFC/VEGFR, CXCR1-2, ELR+CXCL cytokines, targeted therapy, lymphangiogenesis, angiogenesis
Sorensen, James. "Therapeutic Efficacy of a Co-Q10 Analogue in Combating Cachexia and Mortality Induced by Gold-Standard Paediatric Chemotherapy Regimens". Thesis, 2020. https://vuir.vu.edu.au/41826/.
Texto completo da fonteLivros sobre o assunto "Medulloblastoma paediatric"
Taylor, Roger E., Barry L. Pizer, Nancy Tarbell, Alba A. Brandes e Stephen Lowis. Embryonal and pineal tumours. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199651870.003.0009.
Texto completo da fonteCapítulos de livros sobre o assunto "Medulloblastoma paediatric"
Janzen, Laura, e Ute Bartels. "Paediatric Neuro-Oncology: Medulloblastoma". In Physician's Field Guide to Neuropsychology, 133–46. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-8722-1_8.
Texto completo da fonteBellapukonda, Snigdha, e Praneeth Suvvari. "Paediatric Case of Medulloblastoma for Whole Brain Radiotherapy". In Problem Based Learning Discussions in Onco-Anesthesia and Onco-Critical Care, 203–12. Singapore: Springer Nature Singapore, 2024. http://dx.doi.org/10.1007/978-981-99-6339-3_19.
Texto completo da fonteShahi, Mehdi Hayat. "Mitogen-activated protein (MAP) kinase Roles in Paediatric Brain Tumor “Medulloblastoma”". In Role of Signaling Pathways in Brain Tumorigenesis, 209–18. Singapore: Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-15-8473-2_18.
Texto completo da fonteNelson, M., C. Diebler e W. St C. Forbes. "Paediatric medulloblastoma: atypical CT features at presentation in the SIOP II trial". In Proceedings of the XIV Symposium Neuroradiologicum, 516–17. Berlin, Heidelberg: Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-49329-4_191.
Texto completo da fonteTalamonti, Cinzia, Stefano Piffer, Daniela Greto, Monica Mangoni, Antonio Ciccarone, Paolo Dicarolo, Maria Evelina Fantacci et al. "Radiomic and Dosiomic Profiling of Paediatric Medulloblastoma Tumours Treated with Intensity Modulated Radiation Therapy". In Computer Analysis of Images and Patterns, 56–64. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-29930-9_6.
Texto completo da fonteYoung, A. "Craniotomy for medulloblastoma". In Paediatric Anaesthesia, 81–85. CRC Press, 2004. http://dx.doi.org/10.3109/9780203413012-15.
Texto completo da fonteMassimino, Maura, Eric Bouffet e Vijay Ramaswamy. "Embryonal Tumours". In Oxford Textbook of Cancer in Children, 188–97. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198797210.003.0023.
Texto completo da fonteTrabalhos de conferências sobre o assunto "Medulloblastoma paediatric"
Lyman, Stephanie. "730 An exploration of existing and potential novel biomarkers in paediatric medulloblastoma". In Royal College of Paediatrics and Child Health, Abstracts of the RCPCH Conference, Liverpool, 28–30 June 2022. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2022. http://dx.doi.org/10.1136/archdischild-2022-rcpch.495.
Texto completo da fonteShoji Hayashi, Daniel, Ana Luiza Ongaro Seidinger Conte, Isadora Olenscki Gilli, Gabriel Lopes Centoducatte e José Andrés Yunes. "Identification of genetic profile associated with response to treatment with protein Smoothened (SMO) inhibitors in paediatric medulloblastoma patients". In XXV Congresso de Iniciação Cientifica da Unicamp. Campinas - SP, Brazil: Galoa, 2017. http://dx.doi.org/10.19146/pibic-2017-78106.
Texto completo da fonte